Pharmaxis Ltd
ASX:PXS
Pharmaxis Ltd
ASX:PXS
Price:
0.021
AUD
Market Closed
Market Cap:
AU$15.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pharmaxis Ltd
ASX:PXS
|
AU |
|
B
|
Bell Equipment Ltd
JSE:BEL
|
ZA |
|
UNO Minda Ltd
NSE:UNOMINDA
|
IN |
|
S
|
Swiggy Ltd
NSE:SWIGGY
|
IN |
|
H
|
High Coast Distillery AB (publ)
STO:HIGHCO B
|
SE |
Balance Sheet
Balance Sheet Decomposition
Pharmaxis Ltd
Pharmaxis Ltd
Balance Sheet Decomposition is not available for
Pharmaxis Ltd
Pharmaxis Ltd
Balance Sheet
Pharmaxis Ltd
Pharmaxis Ltd
Currency: AUD
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
2
|
4
|
5
|
31
|
3
|
3
|
10
|
3
|
6
|
|
| Cash |
1
|
2
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
4
|
5
|
31
|
3
|
3
|
9
|
2
|
6
|
|
| Short-Term Investments |
31
|
45
|
35
|
16
|
0
|
28
|
11
|
9
|
6
|
3
|
|
| Total Receivables |
0
|
0
|
5
|
4
|
3
|
7
|
7
|
3
|
8
|
7
|
|
| Accounts Receivables |
0
|
0
|
3
|
1
|
3
|
1
|
1
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
2
|
3
|
0
|
6
|
5
|
1
|
5
|
6
|
|
| Inventory |
0
|
0
|
2
|
3
|
2
|
2
|
3
|
4
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
46
|
29
|
36
|
41
|
24
|
25
|
19
|
19
|
|
| PP&E Net |
0
|
0
|
18
|
15
|
12
|
10
|
9
|
6
|
3
|
2
|
|
| PP&E Gross |
0
|
0
|
18
|
15
|
0
|
10
|
9
|
6
|
3
|
2
|
|
| Accumulated Depreciation |
16
|
19
|
22
|
25
|
0
|
31
|
34
|
37
|
40
|
41
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
66
N/A
|
45
-31%
|
50
+10%
|
53
+5%
|
35
-33%
|
34
-5%
|
25
-25%
|
24
-5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
2
|
3
|
6
|
2
|
2
|
1
|
1
|
3
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Other Current Liabilities |
0
|
0
|
7
|
6
|
1
|
4
|
2
|
4
|
2
|
2
|
|
| Total Current Liabilities |
0
|
0
|
11
|
11
|
8
|
8
|
7
|
8
|
6
|
8
|
|
| Long-Term Debt |
0
|
0
|
9
|
8
|
7
|
6
|
6
|
4
|
2
|
0
|
|
| Other Liabilities |
0
|
0
|
24
|
23
|
24
|
24
|
21
|
19
|
6
|
6
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
45
N/A
|
42
-6%
|
39
-7%
|
38
-3%
|
34
-10%
|
31
-10%
|
14
-53%
|
14
+1%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
345
|
345
|
345
|
367
|
367
|
371
|
380
|
390
|
|
| Retained Earnings |
0
|
0
|
324
|
341
|
334
|
352
|
366
|
369
|
370
|
380
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
21
N/A
|
4
-83%
|
11
+216%
|
15
+33%
|
1
-90%
|
3
+99%
|
11
+280%
|
10
-12%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
66
N/A
|
45
-31%
|
50
+10%
|
53
+5%
|
35
-33%
|
34
-5%
|
25
-25%
|
24
-5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
317
|
319
|
320
|
394
|
395
|
453
|
549
|
720
|
|
Switch to:
Switch to:
See Also
Discover More
